Statistics
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
| Views | |
|---|---|
| Evaluating ... | 1380 |
Total Visits Per Month
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluating ... | 5 | 14 | 18 | 18 | 21 | 27 | 9 |
File Visits
| Views | |
|---|---|
| 21VmhogDXFlrE.pdf | 723 |